Afya Limited SEC filings document the company as a foreign private issuer reporting on Form 6-K and presenting financial information in Brazilian reais under IFRS. The filings include unaudited interim and annual consolidated financial statements, operating-result releases and balance-sheet disclosures covering cash, receivables, property and equipment, right-of-use assets, intangible assets, loans and financing, lease liabilities and accounts payable to selling shareholders.
The filing record also documents Afya’s capital-allocation actions, including dividend approvals and share repurchase disclosures, as well as medical-seat authorizations for Brazilian campuses and board-governance changes. These reports connect Afya’s education and medical practice solutions business with formal disclosures on capital structure, liquidity, campus approvals, ownership-related obligations and governance matters.
Afya Ltd Controller Welder Ferreira Santos reported an open-market sale of 3,325 Class A common shares. The shares were sold at an average price of $15.90 per share. After this transaction, the insider directly holds 35,000 Class A common shares, indicating the sale represents a relatively small portion of their overall position.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, reported open-market sales of Class A common shares. On April 13, 2026, he sold a total of 14,000 shares in three transactions priced between $15.35 and $15.50 per share. Following these sales, he directly holds 31,000 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza reported an open-market sale of Class A common shares. On April 9, 2026, he sold 16,279 Class A Common Shares at a price of $14.53 per share, leaving him with 0 shares of this security held directly after the transaction.
Afya Ltd Chief Financial Officer sells shares in open-market trade. CFO Luis Andre Carpintero Blanco sold 10,000 Class A common shares of Afya Ltd in an open-market transaction at $15.20 per share. After this sale, he directly holds 51,103 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza sold Class A shares in an open-market trade. He sold 26,753 Class A common shares at $14.95 per share and now directly holds 16,279 shares. This was a straightforward sale of existing stock, with no derivatives reported.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, conducted an open-market sale of 5,000 Class A Common Shares on April 7, 2026 at $15.20 per share. After this transaction, he continues to hold 45,000 Class A Common Shares directly, indicating he retains a substantial personal stake in the company despite trimming his position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A common shares. On April 2, he sold 20,900 shares at $14.94 per share, and on April 6, he sold 770 shares at $14.91 per share.
After these sales, he holds 108,448 Class A shares directly and an additional 200,000 Class A shares indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him. The 21,670 shares sold represent a small portion of his overall position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of 21,820 Class A Common Shares of Afya Ltd over two days. He sold 19,500 shares on April 1, 2026 at $14.98 per share and 2,320 shares on March 31, 2026 at $14.92 per share.
Following these transactions, he holds 130,118 Class A Common Shares directly. He also has an indirect holding of 200,000 Class A Common Shares through GIBBOAT OVERSEAS LTD, which the footnote states is solely owned and controlled by him.
Afya Limited files its annual report prepared under IFRS, presenting consolidated results in Brazilian reais with convenience translations at R$5.5024 per US$1.00. The company operates a large medical and health‑education ecosystem in Brazil through undergraduate, continuing education and digital medical solutions.
The report emphasizes extensive risk factors: intense competition in medical and graduate education, rapid technological change including artificial intelligence, and heavy exposure to Brazilian regulation of medical school openings and enrollment caps. Afya is also highly dependent on government programs such as FIES and PROUNI, Brazilian tax reform (IBS, CBS, Pillar Two and a new 10% dividend withholding), and close MEC supervision via ENADE and ENAMED scores, which can trigger sanctions affecting seats, programs and access to public funding.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A Common Shares. He sold 1,510 shares at $14.91 per share on March 30, 2026 and 300 shares at $15.00 per share on March 27, 2026, totaling 1,810 shares sold.
After these transactions, he directly holds 151,938 Class A Common Shares. In addition, 200,000 Class A Common Shares are held indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him, indicating a substantially larger remaining overall position.